secwatch.observer — SEC 8-K summary
======================================

Issuer:     Monopar Therapeutics (MNPR)
CIK:        0001645469
Form:       8-K
Filed at:   2026-06-23T12:00:40+00:00
Accession:  0001437749-26-021350
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Monopar shareholders re-elect all directors, approve 2026 stock plan, ratify BPM
--------------------------------------------------------------------------------

- All six director nominees elected: Starr (4.20M for), Robinson (4.45M), Anderson (4.67M), Tsuchimoto (4.33M), Talukdar (4.90M), Sweeny (4.91M).
- Advisory say-on-pay passed with 4.36M for, 605k against, 651 abstain.
- 2026 Stock Incentive Plan approved with 4.44M for, 517k against.
- Ratification of BPM LLP as auditor for FY2026 passed with 5.76M for, 998 against.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1645469/000143774926021350/0001437749-26-021350-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1645469/000143774926021350/mnpr20260622_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-021350

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer